Evidence map›Paper›PMID 28915636›Full record

ArticleOncotarget2017

Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer.

Wenming Feng, Ge Cui, Cheng-Wu Tang, Xiao-Lan Zhang, Chuang Dai, Yong-Qiang Xu, Hui Gong, Tao Xue, Hui-Hui Guo, Ying Bao

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wenming FengDepartment of Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Ge CuiDepartment of Pathology, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Cheng-Wu TangDepartment of Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Xiao-Lan ZhangDepartment of Pathology, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Chuang DaiDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Yong-Qiang XuDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Hui GongCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Tao XueCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Hui-Hui GuoCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Ying BaoDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, P.R. China.
Huzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) ranks the third most commonly diagnosed cancer in males and the second in females worldwide. However, the functional and causal SNPs for CRC remain to be mined. Glucose transporter 1 (GLUT1), a pivotal rate-limiting element in the transport of glucose in malignancy cells, has been identified to be associated with many cancers. Here, we aim to explore the role of GLUT1 in the occurrence and prognosis of colorectal cancer in a Chinese population. We found that GLUT1 expression levels in CRC tumor tissues were significantly higher than those in the corresponding adjacent normal tissues, and Cox multivariate analysis demonstrated that the GLUT1 expression was an independent prognostic factor for CRC (HR = 2.11, 95% CI = 1.33-3.34, P=0.001). For a functional polymorphism of GLUT1 (rs710218), we found that individuals with TT genotype (OR = 1.68, 95% CI = 1.02-2.75, P = 0.041) or AT genotype (OR = 1.47, 95% CI = 1.09-1.99, P = 0.012) of rs710218 had a significantly increased risk of CRC compared to those with AA homozygote. These findings strongly suggest that glucose metabolism related gene GLUT1, and its functional SNP, rs710218 might contribute to CRC susceptibility and prognosis, and the exact biological mechanism awaits further research.

Indexed as

colorectal cancerGLUT1polymorphismprognosis

Identifiers

PMID28915636
PMCPMC5593607
OpenAlexW2618572519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.